Polymorphisms in the DBH and DRD2 gene regions and smoking behavior

scientific article published on 21 July 2005

Polymorphisms in the DBH and DRD2 gene regions and smoking behavior is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00406-005-0610-X
P698PubMed publication ID16032443

P50authorMara H. HutzQ30348910
Claiton H D BauQ54016784
P2093author name stringFrancine Z C Marques
Maria Teresa M V Freire
P2860cites workDopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variationQ57418969
The TaqI A1 allele of the dopamine D2 receptor gene and alcoholism in Brazil: Association and interaction with stress and harm avoidance on severity predictionQ61648430
Platelet MAO-B and endogenous MAO-A inhibitory activity in depressed patients: stability with electroconvulsive treatmentQ69394316
TaqI polymorphic sites at the human dopamine beta-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophreniaQ74493051
Common genetic vulnerability for nicotine and alcohol dependence in menQ77987975
Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depressionQ28208179
Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1Q28262025
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locusQ28347490
A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoiaQ28370470
Detecting alcoholism. The CAGE questionnaireQ29616010
Stages in the development of adolescent smokingQ33895599
The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activityQ33904818
Imaging localised dynamic changes in the nucleus accumbens following nicotine withdrawal in ratsQ34326594
D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypesQ35032700
Short term patterns of early smoking acquisitionQ35539036
Human genetics of plasma dopamine beta-hydroxylase activity: applications to research in psychiatry and neurologyQ35747291
Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?Q35877656
Progress in searching for susceptibility loci and genes for smoking-related behaviourQ35915572
Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34.Q36437189
A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studiesQ40507676
The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP.Q40575056
A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA.Q40755655
A polymorphism (A118G) in the mu-opioid receptor gene affects the response to morphine-6-glucuronide in humansQ43843763
A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic functionQ44253186
Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholismQ44692227
The 3' region of the DRD2 gene is involved in genetic susceptibility to schizophreniaQ44740738
Genetic variation in dopaminergic pathways and short-term effectiveness of the nicotine patchQ44839167
Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traitsQ44941663
Low dopamine-beta-hydroxylase: A biological sequela of abuse and neglect?Q45156660
D2 dopamine receptor polymorphism and brain regional glucose metabolismQ46068742
The A1 allele of the human D2 dopamine receptor gene predicts low D2 receptor availability in healthy volunteersQ47806955
PCR detection of the TaqA RFLP at the DRD2 locusQ48090971
Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteersQ48170316
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.Q48563699
Is the polymorphic microsatellite repeat of the dopamine beta-hydroxylase gene associated with biochemical variability of the catecholamine pathway in schizophrenia?Q48754521
Diagnoses, catecholamine metabolism, and plasma dopamine-beta-hydroxylase.Q52071852
P433issue2
P304page(s)93-97
P577publication date2005-07-21
P1433published inEuropean Archives of Psychiatry and Clinical NeuroscienceQ661388
P1476titlePolymorphisms in the DBH and DRD2 gene regions and smoking behavior
P478volume256

Reverse relations

cites work (P2860)
Q36605165A large-scale meta-analysis of the association between the ANKK1/DRD2 Taq1A polymorphism and alcohol dependence
Q37541750A review of psychiatric genetics research in the Brazilian population
Q37732338ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence
Q36255624An initial investigation of associations between dopamine-linked genetic variation and smoking motives in African Americans
Q28264804Association between dopamine beta hydroxylase rs5320 polymorphism and smoking behaviour in elderly Japanese
Q95825809Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias
Q33412991Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data
Q33599863Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort
Q31036731Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer
Q35196495Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar Disorder
Q35783292Genetic polymorphisms in dopamine-related genes and smoking cessation in women: a prospective cohort study
Q36849881Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART).
Q37010016Neuroimaging, genetics and the treatment of nicotine addiction
Q36310463Nur-related receptor 1 gene polymorphisms and alcohol dependence in Mexican Americans
Q35454787Pharmacogenetic aspects of addictive behaviors
Q34644603Regulatory polymorphisms in human DBH affect peripheral gene expression and sympathetic activity
Q43861803The 5-HT(2A) -1438G/A polymorphism in anorexia nervosa: a combined analysis of 316 trios from six European centres
Q33650590The Influence of Major Life Events on Economic Attitudes in a World of Gene-Environment Interplay
Q40197322Tobacco smoking and the ADRA2A C-1291G polymorphism